טוען...
Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
PURPOSE: The introduction of ligands targeting prostate-specific membrane antigen (PSMA), especially (68)Ga-PSMA-11, has changed the management of patients with prostate cancer (PCa). (18)F-Labelled ligands can be produced in larger amounts and therefore can improve availability for a larger group o...
שמור ב:
| הוצא לאור ב: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182394/ https://ncbi.nlm.nih.gov/pubmed/30027419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4089-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|